According to published reports, New Jersey-are pharma companies have collectively shed around 200,000 jobs, measuring only as far back as 2005.
That means the $3.6 million in retraining aid allocated in New Jersey (see below) will have to be spread thinly over those laid-off — as there are just so many former pharma people out of work.
Even so, it is some good news, per NJBiz.com. Do go read it all, but here is a bit:
. . . .The [New Jersey] state Department of Labor and Workforce Development on Friday announced the availability of $3.6 million in federal funding for retraining and re-employment opportunities for pharmaceutical workers who have been laid off.
Among the eligible workers are those who have worked at such companies as Amicus Therapeutics, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co. and Pfizer, according to Labor. . . .
The grant funding will be used to assist workers who were laid off from specific pharmaceutical operations to find new jobs, or to obtain training to enter employment in other growing industry sectors. Services available include skills assessment, career counseling and skills training; qualified candidates may receive up to $5,000 in education grants. . . .
It is something — true enough — but nothing near what’s needed, to fully redeploy this workforce. Make no mistake, the jobs they once held are not coming back — at least not to any facility in the United States.